<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01042197</url>
  </required_header>
  <id_info>
    <org_study_id>H-B-2007-100</org_study_id>
    <nct_id>NCT01042197</nct_id>
  </id_info>
  <brief_title>The Relation Between Vitamin D Production and UVB Exposed Body Surface Area</brief_title>
  <official_title>Interdependence Between Body Surface Area and UVB Dose in Vitamin D Production: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vejle Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the relation between vitamin D production after
      UVB and exposed body surface areas with different UVB doses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin D deficiency is very common. Rachitis, osteoporosis, cancer, sclerosis as well as
      cardiovascular diseases are related to vitamin D deficiency. Elderly people, immigrants as
      well as patients with malabsorption diseases often have vitamin D deficiency. 90-95 % of the
      total vitamin D requirements are obtained from the ultraviolet (UV) radiation of the skin.In
      spite of the risk of skin-cancer, treatment with sunlight radiation is often recommended
      against vitamin D deficiency. This fact has raised a scientific debate, where concern has
      been expressed with regard to the risk of skin-cancer. This dilemma should also be examined
      as no human studies are available on the vitamin D production in the skin after UV-radiation
      showing the frequency and dose necessary for sufficient production of vitamin D. The lowest
      exposure frequency, the smallest body surface area and the lowest UV dose should therefore be
      established to be exposed in order to minimize the risk of skin-cancer by unnecessary
      UV-radiation. The purpose of the project is therefore to clarify which factors there are of
      importance for the production of vitamin D in the skin after UVB radiation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vitamin D (nmol/l) measured in a blood sample to define just how much sun exposure is necessary to obtain a sufficient vitamin D production.</measure>
    <time_frame>Before and 2 days after the last UVB session.</time_frame>
  </primary_outcome>
  <number_of_arms>9</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Vitamin D Status</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Body surface area: 12 %</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Body surface area: 6 %</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Body surface area: 24 %</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Body surface area: 6 %</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Body surface area: 12 %</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Body surface area: 24 %</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Body surface area: 6 %</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Body surface area: 12 %</description>
  </arm_group>
  <arm_group>
    <arm_group_label>9</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Body surface area: 24 %</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Broadband UVB</intervention_name>
    <description>UVB dose: 0.75 SED. Four UVB sessions with 2 days in between.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Broadband UVB</intervention_name>
    <description>UVB dose: 0.75 SED. Four UVB sessions with 2 days in between.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Broadband UVB</intervention_name>
    <description>UVB dose: 0.75 SED. Four UVB sessions with 2 days in between.</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Broadband UVB</intervention_name>
    <description>UVB dose: 1.5 SED. Four UVB sessions with 2 days in between.</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Broadband UVB</intervention_name>
    <description>UVB dose: 1.5 SED. Four UVB sessions with 2 days in between.</description>
    <arm_group_label>5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Broadband UVB</intervention_name>
    <description>UVB dose: 1.5 SED. Four UVB sessions with 2 days in between.</description>
    <arm_group_label>6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Broadband UVB</intervention_name>
    <description>UVB dose: 3.0 SED. Four UVB sessions with 2 days in between.</description>
    <arm_group_label>7</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Broadband UVB</intervention_name>
    <description>UVB dose: 3.0 SED. Four UVB sessions with 2 days in between.</description>
    <arm_group_label>8</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Broadband UVB</intervention_name>
    <description>UVB dose: 3.0 SED. Four UVB sessions with 2 days in between.</description>
    <arm_group_label>9</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy individuals between 18 - 65 years of age.

          -  Avoidance of sun bed exposure

          -  Not Holidaying south of 45 degrees latitude 3 months before

          -  Avoiding vitamin D supplementation during and two months before

        Exclusion Criteria:

          -  Illness as well as age above 65 years.

          -  Skin diseases

          -  Psychiatric diseases

          -  Drug addiction

          -  Intake of photosensitive medicine.

          -  Intake of cholesterol-lowering medicine.

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans Christian Wulf, Full Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Bispebjerg Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bispebjerg Hospital, Department of Dermatology D92, Bispebjerg Bakke 23,</name>
      <address>
        <city>Copenhagen Nv</city>
        <state>Copenhagen</state>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2010</study_first_submitted>
  <study_first_submitted_qc>January 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2010</study_first_posted>
  <last_update_submitted>January 11, 2010</last_update_submitted>
  <last_update_submitted_qc>January 11, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2010</last_update_posted>
  <responsible_party>
    <name_title>Morten Bogh M.D.</name_title>
    <organization>Bispebjerg Hospital, Department of Dermatology</organization>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>UVB</keyword>
  <keyword>Dose-Response</keyword>
  <keyword>Body surface area</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

